Wu, Zhengming http://orcid.org/0000-0002-3738-4605
Su, Junhui
Li, Fu-long
Chen, Tao http://orcid.org/0000-0002-8016-9732
Mayner, Jaimie
Engler, Adam
Ma, Shenghong
Li, Qingquan http://orcid.org/0000-0003-1141-2943
Guan, Kun-Liang
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (CA268179)
Article History
Received: 13 June 2023
Accepted: 7 September 2023
First Online: 22 September 2023
Competing interests
: K.-L.G. is a co-founder of and holds an equity interest in Vivace Therapeutics. All other authors declare no competing interests.